Pierre Fabre
New ways to care  

Toulouse, June 20, 2025 - Pierre Fabre Laboratories announces the appointment of Audrey Ricard Campion as Head of Research and Development for its Dermo-Cosmetics & Personal Care business. Reporting to Frédéric Ennabli, CEO of Pierre Fabre Dermo-Cosmetics, she will join the Executive Committee and will be responsible for defining and implementing the company’s innovation strategy. An engineering graduate in physics and chemistry, Audrey Ricard Campion has acquired in-depth expertise in the science of skin over the course of her career. Her work, characterized by the encapsulation and vectorization of active ingredients and pigments, as well as the use of adhesive polymers, has given rise to numerous patents, particularly in the fields of photoprotection and facial skincare. Audrey will now be putting her experience to work for Pierre Fabre Laboratories' Dermo-Cosmetics & Personal Care portfolio, which includes major international brands such as Eau Thermale Avène, Ducray, Klorane, A-Derma, René Furterer and Elgydium. Audrey Ricard Campion will be based at the Pierre Fabre Innovation Center, on the Oncopole campus in Toulouse. She will head up an organization of 420 employees based mainly in Toulouse, as well as in the innovation centers in Shanghai, specializing in Asian skin types, and Rio de Janeiro, specializing in skin types found in South America.  She will be able to draw on multidisciplinary expertise, including biology, clinical pharmacology, biotechnology and formulation, to support priority fields of research such as sun protection, acne treatment, atopy, skin repair and alopecia.

SECAUCUS, NJ (June 18, 2025): Pierre Fabre Laboratories, a global healthcare company originated from France, announces the inauguration of its new US office located on 500 Plaza Drive, in Secaucus, NJ which will host its dermo-cosmetics and medical care subsidiaries. Pierre Fabre is the world’s second-largest dermo-cosmetics manufacturer and a global player in oncology, cell & gene therapy, rare disease and dermatology. This strategic move in the US marks a pivotal moment in the company’s growth strategy, underscoring its strong commitment to advancing in the US in both dermo-cosmetics and medical care. Pierre Fabre Laboratories introduced global dermo-cosmetics brands Avène, Klorane and René Furterer to the US market in the 1990’s. With an ever-growing desire for French dermo-cosmetics, the US dermo-cosmetics business has become a top priority. Building upon their success in oncology and dermatology in Europe and Asia, the company has recently expanded its medical care investments in the US through the creation of a dedicated pharmaceutics unit, Pierre Fabre Pharmaceuticals (PFP). This subsidiary is focused on continuing to deliver breakthrough therapies in rare diseases and oncology to American patient populations with high unmet needs and limited treatment options.

PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed as treatment options for emergent and unmet medical needs in non-small cell lung cancer ("NSCLC")

Find the 2025 annual report (2024 figures) online. We have placed this year’s annual report under the sign of a “new energy” resulting in :  International growth Therapeutic innovations Medical leadership Financial solidity Collective commitment  

Malignant melanoma is a type of skin cancer that starts and develops in cells known as melanocytes – these cells are found in the upper layer of the skin and produce a pigment called melanin, giving skin its colouri. Melanoma, although less common than other skin cancers, is more dangerous because it grows and spreads quickly to other parts of the body if undetected and not treated early.i ii,  Anyone can suffer from melanoma, but it is more commonly reported among light-skinned populations, partly attributable to decreased photoprotection from reduced melanin.ii,iii Recognising the signs and symptoms of melanoma is important for early detection, diagnosis and improved treatment outcomes.iv Skin cancer can develop anywhere on the body; in places we cannot see and would not expect.v Whilst sun-exposed skin is most at risk, unusual changes to skin can also develop in areas that are usually protected from the sun (soles of feet, between fingers and toes, back, etc).v,vi Both self-evaluation and examination by others (including friends, family, or a doctor), are important for checking all areas of your skin for signs of melanoma.vi We Have Your Back Campaign This year, Pierre Fabre is re-launching a campaign entitled ‘We Have Your Back’. 

In line with Pierre Fabre Laboratories' vision "Every time we care for a single person, we make the whole world better" the MSL (Medical Science Liaison) role is crucial in enhancing patient care. As a scientific bridge between the medical community and the Pierre Fabre Laboratories, the MSL combines pharmaceutical innovation with medical expertise to develop collaboration with healthcare professionals and optimize daily healthcare practices. The MSL's objectives can be achieved through various missions, including: Medical Education: promoting best practices for up-to-date patient management. Insight Collection: gaining a comprehensive understanding of patient treatment practices, organization, and patient journey. Data Needs Identification and participation to their generation to promote best practices for patient treatment. Support Clinical Development and Real-World Evidence Projects. Understanding patient needs. Click to discover in this infographic the multifaceted life of our MSLs, their missions, skills, and roles at Pierre Fabre Laboratories.   Dive into the MSL experience through a series of 10 monthly interviews. The series will share their professional journeys, highlighting the realities and successes they encounter, and provide a glimpse into their commitment to advancing medical care.   #1  Emeline Mathieu: A Passionate Medical Science Liaison (MSL) Advancing Healthcare in Australia.  #2  Pawel Pedrasik: A Passionate Medical Science Liaison (MSL) Advancing Healthcare in Poland #3 Zohra Butt: A Medical Science Liaison (MSL) Dedicated to Changing Patient Lives in the United Kingdom.  #4 Miaomiao Zhang: A Medical Science Liaison (MSL) Transforming the Therapeutic Landscape in China. #5 Selina Jansky: A Medical Science Liaison (MSL) Leading the Evolution of Healthcare Practices in Germany.